Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Non-Current Debt (2022 - 2024)

Spruce Biosciences (SPRB) has disclosed Non-Current Debt for 3 consecutive years, with $124000.0 as the latest value for Q4 2024.

  • Quarterly Non-Current Debt fell 92.78% to $124000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $124000.0 through Dec 2024, down 92.78% year-over-year, with the annual reading at $124000.0 for FY2024, 92.78% down from the prior year.
  • Non-Current Debt for Q4 2024 was $124000.0 at Spruce Biosciences, down from $524000.0 in the prior quarter.
  • The five-year high for Non-Current Debt was $4.5 million in Q1 2022, with the low at $124000.0 in Q4 2024.
  • Average Non-Current Debt over 3 years is $2.3 million, with a median of $2.3 million recorded in 2023.
  • The sharpest move saw Non-Current Debt plummeted 35.32% in 2023, then tumbled 92.78% in 2024.
  • Over 3 years, Non-Current Debt stood at $3.3 million in 2022, then plummeted by 47.86% to $1.7 million in 2023, then crashed by 92.78% to $124000.0 in 2024.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $124000.0, $524000.0, and $923000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.